As the #SGO2025 Annual Meeting wraps up, we’re grateful for the meaningful connections and conversations with investigators leading the charge in ovarian #cancer clinical research. These conversations come at an exciting time for us, as we recently opened expansion cohorts in our #clinicaltrial evaluating our novel #KIF18A inhibitor. We appreciate the collaboration and momentum as we work to advance new options for patients. Society of Gynecologic Oncology #Oncology #Biotech #ClinicalResearch #SGOMtg #AM25IMPACT Pictured: Timothy Bowler and Linda Lee
Volastra Therapeutics
生物技术
New York,New York 5,132 位关注者
Clinical stage biotech developing a powerful new class of cancer therapies exploiting chromosomal instability.
关于我们
Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most targetable vulnerability. Founded by Lewis Cantley, Ph.D., Olivier Elemento, Ph.D., and Samuel Bakhoum, M.D., Ph.D., Volastra is advancing a novel synthetic lethal and immune activating pipeline. Leading its portfolio, Volastra has two KIF18A inhibitors in Phase 1 clinical trials for cancers with high levels of chromosomal instability.
- 网站
-
https://www.volastratx.com
Volastra Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- New York,New York
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
1361 Amsterdam Ave
520
US,New York,New York,10027
Volastra Therapeutics员工
动态
-
We're Hiring: Data Engineer/Senior Data Engineer Volastra Therapeutics is expanding our data capabilities and looking for a Data Engineer/Senior Data Engineer to help build and maintain scalable data infrastructure that powers groundbreaking oncology research. ? In this role, you'll work closely with scientists and researchers to design data pipelines, optimize cloud-based storage solutions, and develop tools that enable data-driven decision-making. If you're passionate about leveraging data to advance cancer research and thrive in a fast-paced biotech environment, we’d like to hear from you! https://lnkd.in/gQUumViq #BiotechCareers #DataEngineering #Oncology?#JoinOurTeam #VolastraTherapeutics #Hiring?#NYCJobs
-
-
Exciting News: Our Clinical Team is Growing! Volastra Therapeutics is expanding, and we’re thrilled to announce three exciting opportunities to join our clinical team: ?? Senior/Medical Director, Oncology?– Play a key role in advancing our clinical trials by providing medical oversight, contributing to trial design, and collaborating with cross-functional teams to deliver impactful results ?? Clinical Scientist (Manager/Senior Manager), Oncology?– Ensure the scientific integrity?of our clinical trials, support data review, and collaborate on key deliverables to drive success ?? Scientist/Manager, Translational Science and Biomarkers?– Design and execute biomarker programs and translational science investigations to support clinical development If you're ready to make an impact, collaborate with a talented group of professionals, and contribute to cutting-edge research, we’d love to hear from you!??All roles are based in NYC, with hybrid flexibility. https://lnkd.in/eq_q7Rgm ? https://lnkd.in/eQdT5j89 https://lnkd.in/en3qJ_4F ? #BiotechCareers #Oncology #ClinicalResearch #ClinicalTrials #JoinOurTeam #VolastraTherapeutics #Hiring?#NYCJobs
-
-
We’re Hiring: Scientist / Senior Scientist, Protein Biochemistry This role will focus on designing and executing cutting-edge protein science experiments, contributing to assay development, and being part of our mission of targeting chromosomal instability in cancer. If you’re a highly skilled protein scientist with expertise in enzymology and biophysical tools, and you're ready to make an impact in a fast-paced biotech environment, we’d like to hear from you! ? https://lnkd.in/difzJTfu ? #ProteinBiochemistry #OncologyResearch #BiotechCareers #JoinOurTeam #VolastraTherapeutics #Hiring #NowHiring #NYCJobs
-
-
We’re thrilled to announce that our paper, ‘Targeting chromosomally unstable tumors with a selective KIF18A inhibitor’, has been published in Nature Communications! This work highlights the journey of preclinical target validation and inhibitor development for KIF18A. This achievement is a testament to our team’s dedication to making a meaningful difference in cancer treatment. With two KIF18A inhibitors, Sovilnesib and VLS-1488, now in clinical trials, we’re one step closer to bringing new treatment options to cancer patients. Check out our paper here: https://lnkd.in/e-Ued5fx PDF access: https://rdcu.be/d5o2A Congratulations to our incredible team and collaborators on this important milestone! #VolastraTherapeutics #CancerResearch #KIF18A #ClinicalTrials #NatureCommunications
-
Volastra Therapeutics is seeking a talented Clinical Research Associate (CRA) to join our team. This role will support key clinical trial operations, from start-up to close-out, driving progress in our mission to revolutionize oncology research. If you’re detail-oriented, collaborative, and eager to thrive in a fast-paced biotech environment, this could be the perfect opportunity to grow your career. https://lnkd.in/eHBSvA_i ? #Hiring #ClinicalResearch #ClinicalTrials?#LifeSciences?#BiotechCareers #Oncology?#VolastraTherapeutics #NowHiring #NYCJobs
-
-
Over the past five years, our team has focused on developing innovative therapies targeting #chromosomal_instability (CIN)—a major driver of cancer progression—to unlock a new frontier in #cancer treatment. Our journey to the clinic with our two #clinical-stage, oral #KIF18A inhibitors highlights the power of strong translational science. In his latest article, our Head of R&D and Chief Medical Officer, Scott Drutman MD PhD shares insights into how we successfully translated scientific discoveries into clinical development.
-
Last week, we gathered at Volastra for a Thanksgiving celebration. It was a joy to come together, share a meal, and reflect on the amazing work we’re doing to make a difference for patients. We’re thankful for our dedicated team and the impact we’re building together. From all of us at Volastra, Happy Thanksgiving to you and your loved ones! ???? #Volastra #Thanksgiving2024
-
-
Join Our Team! Volastra Therapeutics is seeking a detail-oriented Clinical Trial Associate. This?role will support our oncology clinical trials, driving excellence in execution and helping us bring new treatments to patients. If you’re passionate about advancing clinical research in a collaborative, fast-paced environment, check out the full role description and apply here: https://lnkd.in/enN9bExa #Hiring #ClinicalTrials #OncologyResearch #LifeSciences?#BiotechCareers #Oncology?#VolastraTherapeutics #NowHiring #NYCJobs
-
-
We were thrilled to participate in the 2nd Annual Life Sciences Day last week, hosted by Life Science Cares New York. Volastra had the pleasure of hosting more than 50 high school students at our state-of-the art Harlem-based lab, giving them a behind-the-scenes look at how cancer therapies are developed and the various career opportunities that exist at biotechnology companies. Our team shared insights into the science, dedication, and collaboration that fuel our development of novel cancer therapies. A huge thank you to Life Science Cares and everyone who made this day possible – we look forward to continued partnership and many more impactful events ahead. #LifeSciences #Biotech #FutureLeaders #Oncology
Thank You to Everyone for Making the 2nd Annual Life Sciences Day 2024 a Success! What an inspiring collaboration across New York City's life science community! A huge thank you to Monica Malowney, M.P.H., Mikko Baylosis, and New York City Economic Development Corporation for being our lead sponsors—your support brought this vision to life. Opening Remarks?from Viq Pervaaz, Seema Kumar, Mark Viech, and Pablo Legorreta?set the stage perfectly with words of wisdom and encouragement for our next generation of scientists. Kyesha Ruffin M. Ed.?and Science in the City, thank you for partnering with us to bring 250 students into the heart of the life sciences industry, giving them a first-hand look at career possibilities. And a special thanks to Coefficient Health?for creating our event map and to Freshfields?for helping to?sponsor this incredible day. Cheers to the SIX Life?Sciences Buildings and Companies?who hosted these students, making their experience truly unforgettable: Alexandria LaunchLabs, Biolabs@NYULangone, Cure., SOSV/IndieBio, Taystee Lab Building (Janus Property Company), Innovation Triangle - West Harlem, and West End Labs. Of course, a big round of applause goes to the dedicated students and teachers who joined us from these fantastic schools: Belmont Prep High School, Cristo Rey New York High School, DREAM Charter School, Eagle Academy for Young Men, East Harlem Tutorial Program, High School for Health Professions & Human Services, International Baccalaureate World School, John Dewey High School, The Judith S. Kaye High School, The Laboratory School of Finance & Technology,?and Thurgood Marshall Academy for Learning & Social Change. Your commitment to excellence is inspiring! This day is a true reflection of Life Science Cares, Inc. — connecting industry professionals with the next wave of scientists and innovators. ? Thank you to everyone who joined us for lunch, and a shoutout to Russell Reynolds Associates, Rose Mistri Somers, and Cure.?for the swag!